866-997-4948(US-Canada Toll Free)

Global Immuno-oncology Drugs Sales Market Report 2018

Published By :

QYResearch

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 127 Pages

This report studies the global Immuno-oncology Drugs market status and forecast, categorizes the global Immuno-oncology Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The global Immuno-oncology Drugs market is valued at 49200 million US$ in 2017 and will reach 142200 million US$ by the end of 2025, growing at a CAGR of 14.2% during 2018-2025.

The major players covered in this report
Amgen, Inc
AstraZeneca, Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie, Inc.
Pfizer Inc.
Sanofi S.A.
EMD Serono, Inc.
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics
ImmunoCellular Therapeutics
Incyte

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Pharmacies
Online Pharmacies

The study objectives of this report are:
To analyze and study the global Immuno-oncology Drugs sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Immuno-oncology Drugs players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Immuno-oncology Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Immuno-oncology Drugs Manufacturers
Immuno-oncology Drugs Distributors/Traders/Wholesalers
Immuno-oncology Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Immuno-oncology Drugs market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents

Global Immuno-oncology Drugs Sales Market Report 2018
1 Immuno-oncology Drugs Market Overview
1.1 Product Overview and Scope of Immuno-oncology Drugs
1.2 Classification of Immuno-oncology Drugs by Product Category
1.2.1 Global Immuno-oncology Drugs Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Immuno-oncology Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Immune Checkpoint Inhibitors
1.2.4 Monoclonal Antibodies
1.2.5 Cytokine-Based Immunotherapy
1.2.6 Cancer Vaccines
1.2.7 CAR-T Cell Therapy
1.3 Global Immuno-oncology Drugs Market by Application/End Users
1.3.1 Global Immuno-oncology Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Hospitals
1.3.2 Pharmacies
1.3.3 Online Pharmacies
1.4 Global Immuno-oncology Drugs Market by Region
1.4.1 Global Immuno-oncology Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Immuno-oncology Drugs Status and Prospect (2013-2025)
1.4.3 Europe Immuno-oncology Drugs Status and Prospect (2013-2025)
1.4.4 China Immuno-oncology Drugs Status and Prospect (2013-2025)
1.4.5 Japan Immuno-oncology Drugs Status and Prospect (2013-2025)
1.4.6 Southeast Asia Immuno-oncology Drugs Status and Prospect (2013-2025)
1.4.7 India Immuno-oncology Drugs Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Immuno-oncology Drugs (2013-2025)
1.5.1 Global Immuno-oncology Drugs Sales and Growth Rate (2013-2025)
1.5.2 Global Immuno-oncology Drugs Revenue and Growth Rate (2013-2025)

2 Global Immuno-oncology Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Immuno-oncology Drugs Market Competition by Players/Suppliers
2.1.1 Global Immuno-oncology Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Immuno-oncology Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Immuno-oncology Drugs (Volume and Value) by Type
2.2.1 Global Immuno-oncology Drugs Sales and Market Share by Type (2013-2018)
2.2.2 Global Immuno-oncology Drugs Revenue and Market Share by Type (2013-2018)
2.3 Global Immuno-oncology Drugs (Volume and Value) by Region
2.3.1 Global Immuno-oncology Drugs Sales and Market Share by Region (2013-2018)
2.3.2 Global Immuno-oncology Drugs Revenue and Market Share by Region (2013-2018)
2.4 Global Immuno-oncology Drugs (Volume) by Application

3 United States Immuno-oncology Drugs (Volume, Value and Sales Price)
3.1 United States Immuno-oncology Drugs Sales and Value (2013-2018)
3.1.1 United States Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
3.1.2 United States Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
3.1.3 United States Immuno-oncology Drugs Sales Price Trend (2013-2018)
3.2 United States Immuno-oncology Drugs Sales Volume and Market Share by Players (2013-2018)
3.3 United States Immuno-oncology Drugs Sales Volume and Market Share by Type (2013-2018)
3.4 United States Immuno-oncology Drugs Sales Volume and Market Share by Application (2013-2018)

4 Europe Immuno-oncology Drugs (Volume, Value and Sales Price)
4.1 Europe Immuno-oncology Drugs Sales and Value (2013-2018)
4.1.1 Europe Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
4.1.2 Europe Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
4.1.3 Europe Immuno-oncology Drugs Sales Price Trend (2013-2018)
4.2 Europe Immuno-oncology Drugs Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Immuno-oncology Drugs Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Immuno-oncology Drugs Sales Volume and Market Share by Application (2013-2018)

5 China Immuno-oncology Drugs (Volume, Value and Sales Price)
5.1 China Immuno-oncology Drugs Sales and Value (2013-2018)
5.1.1 China Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
5.1.2 China Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
5.1.3 China Immuno-oncology Drugs Sales Price Trend (2013-2018)
5.2 China Immuno-oncology Drugs Sales Volume and Market Share by Players (2013-2018)
5.3 China Immuno-oncology Drugs Sales Volume and Market Share by Type (2013-2018)
5.4 China Immuno-oncology Drugs Sales Volume and Market Share by Application (2013-2018)

6 Japan Immuno-oncology Drugs (Volume, Value and Sales Price)
6.1 Japan Immuno-oncology Drugs Sales and Value (2013-2018)
6.1.1 Japan Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
6.1.2 Japan Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
6.1.3 Japan Immuno-oncology Drugs Sales Price Trend (2013-2018)
6.2 Japan Immuno-oncology Drugs Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Immuno-oncology Drugs Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Immuno-oncology Drugs Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Immuno-oncology Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Immuno-oncology Drugs Sales and Value (2013-2018)
7.1.1 Southeast Asia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Immuno-oncology Drugs Sales Price Trend (2013-2018)
7.2 Southeast Asia Immuno-oncology Drugs Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Immuno-oncology Drugs Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Immuno-oncology Drugs Sales Volume and Market Share by Application (2013-2018)

8 India Immuno-oncology Drugs (Volume, Value and Sales Price)
8.1 India Immuno-oncology Drugs Sales and Value (2013-2018)
8.1.1 India Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
8.1.2 India Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
8.1.3 India Immuno-oncology Drugs Sales Price Trend (2013-2018)
8.2 India Immuno-oncology Drugs Sales Volume and Market Share by Players (2013-2018)
8.3 India Immuno-oncology Drugs Sales Volume and Market Share by Type (2013-2018)
8.4 India Immuno-oncology Drugs Sales Volume and Market Share by Application (2013-2018)

9 Global Immuno-oncology Drugs Players/Suppliers Profiles and Sales Data
9.1 Amgen, Inc
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Immuno-oncology Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 AstraZeneca, Plc
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Immuno-oncology Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Bristol-Myers Squibb
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Immuno-oncology Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Celgene Corporation
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Immuno-oncology Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Eli Lilly and Company
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Immuno-oncology Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Merck & Co.
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Immuno-oncology Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Merck & Co. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Hoffmann-La Roche AG
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Immuno-oncology Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Johnson & Johnson
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Immuno-oncology Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Novartis International AG
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Immuno-oncology Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Novartis International AG Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 AbbVie, Inc.
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Immuno-oncology Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Pfizer Inc.
9.12 Sanofi S.A.
9.13 EMD Serono, Inc.
9.14 Gilead Sciences Inc.
9.15 Prometheus Therapeutics & Diagnostics
9.16 Aduro BioTech
9.17 Galena Biopharma
9.18 Bavarian Nordic
9.19 Celldex Therapeutics
9.20 ImmunoCellular Therapeutics
9.21 Incyte

10 Immuno-oncology Drugs Maufacturing Cost Analysis
10.1 Immuno-oncology Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Immuno-oncology Drugs
10.3 Manufacturing Process Analysis of Immuno-oncology Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Immuno-oncology Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Immuno-oncology Drugs Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Immuno-oncology Drugs Market Forecast (2018-2025)
14.1 Global Immuno-oncology Drugs Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Immuno-oncology Drugs Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Immuno-oncology Drugs Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Immuno-oncology Drugs Price and Trend Forecast (2018-2025)
14.2 Global Immuno-oncology Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Immuno-oncology Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Immuno-oncology Drugs Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Immuno-oncology Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Immuno-oncology Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Immuno-oncology Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Immuno-oncology Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Immuno-oncology Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Immuno-oncology Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Immuno-oncology Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Immuno-oncology Drugs Sales Forecast by Type (2018-2025)
14.3.2 Global Immuno-oncology Drugs Revenue Forecast by Type (2018-2025)
14.3.3 Global Immuno-oncology Drugs Price Forecast by Type (2018-2025)
14.4 Global Immuno-oncology Drugs Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Immuno-oncology Drugs
Figure Global Immuno-oncology Drugs Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Immuno-oncology Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Immune Checkpoint Inhibitors Product Picture
Figure Monoclonal Antibodies Product Picture
Figure Cytokine-Based Immunotherapy Product Picture
Figure Cancer Vaccines Product Picture
Figure CAR-T Cell Therapy Product Picture
Figure Global Immuno-oncology Drugs Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Immuno-oncology Drugs by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Pharmacies Examples
Table Key Downstream Customer in Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Global Immuno-oncology Drugs Market Size (Million USD) by Regions (2013-2025)
Figure United States Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Immuno-oncology Drugs Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Immuno-oncology Drugs Sales Volume (K Units) (2013-2018)
Table Global Immuno-oncology Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Immuno-oncology Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Immuno-oncology Drugs Sales Share by Players/Suppliers
Figure 2017 Immuno-oncology Drugs Sales Share by Players/Suppliers
Figure Global Immuno-oncology Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Immuno-oncology Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Immuno-oncology Drugs Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Immuno-oncology Drugs Revenue Share by Players
Table 2017 Global Immuno-oncology Drugs Revenue Share by Players
Table Global Immuno-oncology Drugs Sales (K Units) and Market Share by Type (2013-2018)
Table Global Immuno-oncology Drugs Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Immuno-oncology Drugs by Type (2013-2018)
Figure Global Immuno-oncology Drugs Sales Growth Rate by Type (2013-2018)
Table Global Immuno-oncology Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Immuno-oncology Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Immuno-oncology Drugs by Type (2013-2018)
Figure Global Immuno-oncology Drugs Revenue Growth Rate by Type (2013-2018)
Table Global Immuno-oncology Drugs Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Immuno-oncology Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Immuno-oncology Drugs by Region (2013-2018)
Figure Global Immuno-oncology Drugs Sales Growth Rate by Region in 2017
Table Global Immuno-oncology Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Immuno-oncology Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Immuno-oncology Drugs by Region (2013-2018)
Figure Global Immuno-oncology Drugs Revenue Growth Rate by Region in 2017
Table Global Immuno-oncology Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Immuno-oncology Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Immuno-oncology Drugs by Region (2013-2018)
Figure Global Immuno-oncology Drugs Revenue Market Share by Region in 2017
Table Global Immuno-oncology Drugs Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Immuno-oncology Drugs Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Immuno-oncology Drugs by Application (2013-2018)
Figure Global Immuno-oncology Drugs Sales Market Share by Application (2013-2018)
Figure United States Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure United States Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Immuno-oncology Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table United States Immuno-oncology Drugs Sales Volume (K Units) by Players (2013-2018)
Table United States Immuno-oncology Drugs Sales Volume Market Share by Players (2013-2018)
Figure United States Immuno-oncology Drugs Sales Volume Market Share by Players in 2017
Table United States Immuno-oncology Drugs Sales Volume (K Units) by Type (2013-2018)
Table United States Immuno-oncology Drugs Sales Volume Market Share by Type (2013-2018)
Figure United States Immuno-oncology Drugs Sales Volume Market Share by Type in 2017
Table United States Immuno-oncology Drugs Sales Volume (K Units) by Application (2013-2018)
Table United States Immuno-oncology Drugs Sales Volume Market Share by Application (2013-2018)
Figure United States Immuno-oncology Drugs Sales Volume Market Share by Application in 2017
Figure Europe Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Immuno-oncology Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Immuno-oncology Drugs Sales Volume (K Units) by Players (2013-2018)
Table Europe Immuno-oncology Drugs Sales Volume Market Share by Players (2013-2018)
Figure Europe Immuno-oncology Drugs Sales Volume Market Share by Players in 2017
Table Europe Immuno-oncology Drugs Sales Volume (K Units) by Type (2013-2018)
Table Europe Immuno-oncology Drugs Sales Volume Market Share by Type (2013-2018)
Figure Europe Immuno-oncology Drugs Sales Volume Market Share by Type in 2017
Table Europe Immuno-oncology Drugs Sales Volume (K Units) by Application (2013-2018)
Table Europe Immuno-oncology Drugs Sales Volume Market Share by Application (2013-2018)
Figure Europe Immuno-oncology Drugs Sales Volume Market Share by Application in 2017
Figure China Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure China Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Immuno-oncology Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table China Immuno-oncology Drugs Sales Volume (K Units) by Players (2013-2018)
Table China Immuno-oncology Drugs Sales Volume Market Share by Players (2013-2018)
Figure China Immuno-oncology Drugs Sales Volume Market Share by Players in 2017
Table China Immuno-oncology Drugs Sales Volume (K Units) by Type (2013-2018)
Table China Immuno-oncology Drugs Sales Volume Market Share by Type (2013-2018)
Figure China Immuno-oncology Drugs Sales Volume Market Share by Type in 2017
Table China Immuno-oncology Drugs Sales Volume (K Units) by Application (2013-2018)
Table China Immuno-oncology Drugs Sales Volume Market Share by Application (2013-2018)
Figure China Immuno-oncology Drugs Sales Volume Market Share by Application in 2017
Figure Japan Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Immuno-oncology Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Immuno-oncology Drugs Sales Volume (K Units) by Players (2013-2018)
Table Japan Immuno-oncology Drugs Sales Volume Market Share by Players (2013-2018)
Figure Japan Immuno-oncology Drugs Sales Volume Market Share by Players in 2017
Table Japan Immuno-oncology Drugs Sales Volume (K Units) by Type (2013-2018)
Table Japan Immuno-oncology Drugs Sales Volume Market Share by Type (2013-2018)
Figure Japan Immuno-oncology Drugs Sales Volume Market Share by Type in 2017
Table Japan Immuno-oncology Drugs Sales Volume (K Units) by Application (2013-2018)
Table Japan Immuno-oncology Drugs Sales Volume Market Share by Application (2013-2018)
Figure Japan Immuno-oncology Drugs Sales Volume Market Share by Application in 2017
Figure Southeast Asia Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Immuno-oncology Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Immuno-oncology Drugs Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Immuno-oncology Drugs Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Immuno-oncology Drugs Sales Volume Market Share by Players in 2017
Table Southeast Asia Immuno-oncology Drugs Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Immuno-oncology Drugs Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Immuno-oncology Drugs Sales Volume Market Share by Type in 2017
Table Southeast Asia Immuno-oncology Drugs Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Immuno-oncology Drugs Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Immuno-oncology Drugs Sales Volume Market Share by Application in 2017
Figure India Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure India Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Immuno-oncology Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table India Immuno-oncology Drugs Sales Volume (K Units) by Players (2013-2018)
Table India Immuno-oncology Drugs Sales Volume Market Share by Players (2013-2018)
Figure India Immuno-oncology Drugs Sales Volume Market Share by Players in 2017
Table India Immuno-oncology Drugs Sales Volume (K Units) by Type (2013-2018)
Table India Immuno-oncology Drugs Sales Volume Market Share by Type (2013-2018)
Figure India Immuno-oncology Drugs Sales Volume Market Share by Type in 2017
Table India Immuno-oncology Drugs Sales Volume (K Units) by Application (2013-2018)
Table India Immuno-oncology Drugs Sales Volume Market Share by Application (2013-2018)
Figure India Immuno-oncology Drugs Sales Volume Market Share by Application in 2017
Table Amgen, Inc Basic Information List
Table Amgen, Inc Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen, Inc Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure Amgen, Inc Immuno-oncology Drugs Sales Global Market Share (2013-2018)
Figure Amgen, Inc Immuno-oncology Drugs Revenue Global Market Share (2013-2018)
Table AstraZeneca, Plc Basic Information List
Table AstraZeneca, Plc Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca, Plc Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure AstraZeneca, Plc Immuno-oncology Drugs Sales Global Market Share (2013-2018)
Figure AstraZeneca, Plc Immuno-oncology Drugs Revenue Global Market Share (2013-2018)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Immuno-oncology Drugs Sales Global Market Share (2013-2018
Figure Bristol-Myers Squibb Immuno-oncology Drugs Revenue Global Market Share (2013-2018)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Celgene Corporation Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure Celgene Corporation Immuno-oncology Drugs Sales Global Market Share (2013-2018)
Figure Celgene Corporation Immuno-oncology Drugs Revenue Global Market Share (2013-2018)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company Immuno-oncology Drugs Sales Global Market Share (2013-2018)
Figure Eli Lilly and Company Immuno-oncology Drugs Revenue Global Market Share (2013-2018)
Table Merck & Co. Basic Information List
Table Merck & Co. Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck & Co. Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure Merck & Co. Immuno-oncology Drugs Sales Global Market Share (2013-2018
Figure Merck & Co. Immuno-oncology Drugs Revenue Global Market Share (2013-2018)
Table Hoffmann-La Roche AG Basic Information List
Table Hoffmann-La Roche AG Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hoffmann-La Roche AG Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure Hoffmann-La Roche AG Immuno-oncology Drugs Sales Global Market Share (2013-2018)
Figure Hoffmann-La Roche AG Immuno-oncology Drugs Revenue Global Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Immuno-oncology Drugs Sales Global Market Share (2013-2018
Figure Johnson & Johnson Immuno-oncology Drugs Revenue Global Market Share (2013-2018)
Table Novartis International AG Basic Information List
Table Novartis International AG Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis International AG Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure Novartis International AG Immuno-oncology Drugs Sales Global Market Share (2013-2018)
Figure Novartis International AG Immuno-oncology Drugs Revenue Global Market Share (2013-2018)
Table AbbVie, Inc. Basic Information List
Table AbbVie, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie, Inc. Immuno-oncology Drugs Sales Growth Rate (2013-2018)
Figure AbbVie, Inc. Immuno-oncology Drugs Sales Global Market Share (2013-2018)
Figure AbbVie, Inc. Immuno-oncology Drugs Revenue Global Market Share (2013-2018)
Table Pfizer Inc. Basic Information List
Table Sanofi S.A. Basic Information List
Table EMD Serono, Inc. Basic Information List
Table Gilead Sciences Inc. Basic Information List
Table Prometheus Therapeutics & Diagnostics Basic Information List
Table Aduro BioTech Basic Information List
Table Galena Biopharma Basic Information List
Table Bavarian Nordic Basic Information List
Table Celldex Therapeutics Basic Information List
Table ImmunoCellular Therapeutics Basic Information List
Table Incyte Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immuno-oncology Drugs
Figure Manufacturing Process Analysis of Immuno-oncology Drugs
Figure Immuno-oncology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Immuno-oncology Drugs Major Players in 2017
Table Major Buyers of Immuno-oncology Drugs
Table Distributors/Traders List
Figure Global Immuno-oncology Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Immuno-oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Immuno-oncology Drugs Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Immuno-oncology Drugs Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Immuno-oncology Drugs Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Immuno-oncology Drugs Sales Volume Market Share Forecast by Regions in 2025
Table Global Immuno-oncology Drugs Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Immuno-oncology Drugs Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Immuno-oncology Drugs Revenue Market Share Forecast by Regions in 2025
Figure United States Immuno-oncology Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Immuno-oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Immuno-oncology Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Immuno-oncology Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure China Immuno-oncology Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Immuno-oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Immuno-oncology Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Immuno-oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Immuno-oncology Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Immuno-oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Immuno-oncology Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Immuno-oncology Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Immuno-oncology Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure Global Immuno-oncology Drugs Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Immuno-oncology Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Immuno-oncology Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Immuno-oncology Drugs Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Immuno-oncology Drugs Sales (K Units) Forecast by Application (2018-2025)
Figure Global Immuno-oncology Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *